Upcoming events

Intersectionality: Examining Concepts of Privilege

When: Tuesday, May 11, 2021 

Time: 4 p.m. - 6 p.m.

Workshop facilitator: Vicki T. Sapp, Ph.D. 

Workshop moderator: Rhonda Dailey, M.D. 

In the last session of this 3-part workshop, participants will complete pre-work through self-directed learning. Definitions of terms such as institutional power, 4 levels of oppression, privilege and others will be provided. Participants will be expected to draw on lessons learned, tools used in Part 1 and Part 2, and new activities introduced into this training to examine the complexities of their own identities. The selected activities for this training are not designed to make participants feel guilty or ashamed around having or not having privilege, but rather to explore how we ALL have SOME privilege and to learn how to engage our privilege to determine if we want to be an actor, ally and/or accomplice when navigating spaces.

By the end of this session, participants will:

  • Be able to reflect on the impact of privilege on their own life
  • Engage in discussions with colleagues to compare the effects of implicit bias and privilege
  • Synthesize in small group settings the effects of privilege on health equity
  • Analyze ways to mitigate privilege in institutional systems


Human Trafficking: Myths vs. Reality

When: Friday, June 4, 2021

Time: 12 p.m. - 1 p.m. 

The prevalence of human trafficking has reached alarming levels in the United States. To address this widespread crisis, individuals licensed or registered by the Michigan Department of Licensing and Regulatory Affairs (LARA); e.g., physicians, nurses, social workers, pharmacists, and professional counselors all have a new continuing educational requirement which must be met when seeking initial or renewal of an individual's licensure or registration.


This presentation will help attendees meet the requirement of licensing in the State of Michigan through:

  • Understanding the types and venues of human trafficking in Michigan and the United States.
  • Identifying victims of human trafficking in health care settings.
  • Identifying the warning signs of human trafficking in health care settings for adults and minors.
  • Identifying resources for reporting when suspecting a child is a victim of human trafficking.
  • Dispelling myths, unlearning, and relearning together throughout this talk

Guest Speaker:

Dena Nazer, M.D., F.A.A.P., Dr. Nazer is an associate professor of pediatrics at Wayne State University. She is the Medical Director at the Kids-TALK Children's Advocacy Center (CAC) in Detroit. Dr. Nazer is certified by the American Board of Pediatrics in both General Pediatrics and Child Abuse Pediatrics. Dr. Nazer was appointed by the governor to the Human Trafficking Health Advisory Board and served a 3-year term. She teaches locally, nationally and internationally on different aspects of child maltreatment including human trafficking.


Containing COVID-19 with Vaccines: How are we doing and what more can be done?

When: Wednesday, June 9, 2021

Time: 12 p.m. - 1 p.m. 

Guest Speakers:

Paul Kilgore, M.P.H., M.D., is an Associate Professor and Director of research at Wayne State University's College of Pharmacy & Health Sciences.  He has over 25 years-experience working in medicine, public health and areas where infectious diseases thrive.  

Marcus Zervos, M.D., is Division Head, Infectious Diseases, Henry Ford Health System in Detroit,Michigan. He is also Assistant Dean, Global Affairs and Professor of Medicine at Wayne State University. His work has included working with vulnerable populations here and internationally. 

Dr. Kilgore and Dr. Zervos have worked with the Mayor's office and Detroit Health Department on a variety of issues including; expanding testing capacity, mobile testing, control of COVID-19 in vulnerable populations including nursing homes, homeless shelters and participation with the health department in investigations. 

Learning objectives:

  • Identify and describe current COVID-19 trends and disease burden
  • Identify and describe approved COVID-19 vaccines and other vaccines in development pipeline
  • Describe opportunities and tools for addressing vaccine hesitancy in the community